MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi ® ...

In a surprising turn of events, former National Committee member He Zhuguo, once a prominent figure in the tobacco industry, is now collaborating with Hong Kong's Secretary for Food and Health, Dr. LO ...

He Zhuguo has experienced the harsh realities of lung cancer diagnosis and treatment. Transitioning from a successful career in the tobacco industry, he faced chemotherapy that he described as ...

About NeOnc Technologies, Holdings, Inc. NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company focused on the development and commercialization of central nervous system ...

“Dr. Medvec’s strategic value to our company is significant,” said Amir Heshmatpour, NeOnc’s Executive Chairman. “We anticipate receiving significant benefits from her insights and guidance as NeOnc ...

“We are honored to welcome Jimmy to our Board of Directors, where his diverse expertise and talents should serve us well as we continue our innovative work to advance our mission of the treatment of ...

NeOnc Technologies Holdings, Inc. (to be listed on the NASDAQ Global Market under the symbol: NTHI), a clinical-stage medical biotechnology company, today announced the appointment of Dr. Steven L.

"Bader brings a wealth of capital markets and M&A experience to NeOnc,” said Dr. Thomas Chen, Chief Executive Officer of NeOnc. “His extensive finance background will serve us well as we embark on our ...

Eli Lilly and Company today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be presented at the American Association for Cancer Research (AACR) ...

King Charles, who is still receiving cancer treatment, visited the Pharmacy and Pharmacology department at Ulster University Coleraine campus in Northern Ireland ...